SAN FRANCISCO — The year was 2007. To raucous applause, Apple CEO Steve Jobs proudly strode across the Macworld stage to reveal a device that would change history: the iPhone, the first mobile phone to be more tablet than telephone. The same year, a small digital health startup called American Well connected its first patients and doctors online.

Roy Schoenberg
Roy Schoenberg Courtesy American Well

So it felt especially appropriate, in the eyes of CEO Roy Schoenberg, for the Boston-based telemedicine company to be selected last year as a key research partner for the Apple Heart Study, the iPhone maker’s most ambitious health research project to date. The study was designed to see whether the Apple Watch and its heart-rate sensor could properly spot irregularities in people’s heartbeat. American Well linked study participants who got a confirmed abnormal reading to remote clinicians with whom they could talk through their diagnosis.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy